SCHEMBL3976444

SCHEMBL3976444

CCOC(=O)c1occc1-c1cccc(N(Cc2ccccc2)C(C)=O)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSPO P30536 2/20 0.46
LMNA P02545 2/20 0.43
TSHR P16473 1/20 0.43
ALDH1A1 P00352 5/20 0.42
RAB9A P51151 5/20 0.42
LTB4R2 Q9NPC1 4/20 0.42
NPC1 O15118 3/20 0.42
HTT P42858 2/20 0.42
PTGDR2 Q9Y5Y4 1/20 0.42
JAK2 O60674 1/20 0.42
PAX8 Q06710 1/20 0.42
MAPT P10636 3/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
KDM4E B2RXH2 2/20 0.40
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
CRHBP P24387 1/20 0.38
CRHR2 Q13324 1/20 0.38
PKM P14618 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3977129 0.83 TSPO (0.45) TSPOLMNAALDH1A1RAB9ALTB4R2
SCHEMBL3982536 0.78 TSHR (0.47) LMNATSHRALDH1A1RAB9ANPC1
SCHEMBL3977084 0.76 ALDH1A1 (0.52) LMNAALDH1A1RAB9ANPC1HTT
SCHEMBL3977097 0.75 FNTA (0.46) LMNATSHRALDH1A1RAB9ANPC1
SCHEMBL3979353 0.74 KISS1R (0.36) TSPOALDH1A1LTB4R2PTGDR2L3MBTL1
SCHEMBL3976847 0.74 SMN1; SMN2 (0.53) LMNAALDH1A1RAB9ANPC1MAPT
SCHEMBL3978715 0.73 MGLL (0.61) LMNATSHRALDH1A1RAB9ANPC1
SCHEMBL2669092 0.73 GCGR (0.40) TSPOLTB4R2NPC1MEN1KMT2A
SCHEMBL3976513 0.73 KDM4E (0.47) LMNATSHRALDH1A1RAB9ANPC1
SCHEMBL3977130 0.72 ALDH1A1 (0.44) LMNATSHRALDH1A1RAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7514452-B2 2-furancarboxylic acid hydrazides and pharmaceutical compositions containing the same DAINIPPON PHARMACEUTICAL CO., LTD (JP) 2009-04-07 US disclosed
US-20050171196-A1 2-Furancarboxylic acid hydrazides and pharmaceutical compositions containing the same DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2005-08-04 US disclosed
EP-1489077-A1 2-FURANCARBOXYLIC ACID HYDRAZIDES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME DAINIPPON PHARMACEUTICAL CO., LTD. (JP) 2004-12-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050171196-A1 2-Furancarboxylic acid hydrazides and pharmaceutical compositions containing the same GLP1R, GCGR, GPR119 TSPO 2878/4885LMNA 2180/4885TSHR 82/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.